PierianDx Founder and Executive Chairman, Rakesh Nagarajan, highlights strategic considerations for building an effective clinical NGS testing menu that achieves greater control, cost savings, and better care for patients.
Learn from the best in industry
hosted by Pierian
Panelist: Victor Fresco
Moderator: Courtney Scott
In this educational webinar, we will share vital information and best practices for building a high-quality program effectively and efficiently. We will also explore the potential need for consultants or services to help you build your program and how and where they fit into the process.
hosted by Pierian
In this informative webinar, we review the NCCN germline testing guidelines, and gain a better understanding of NGS testing criteria for Familial Prostate Cancer.
hosted by Pierian
In this informative webinar, we shine the light on the NCCN somatic testing guidelines for prostate cancer and discuss critical criteria for ensuring that NGS tests are meeting those guidelines.
hosted by Pierian
This educational webinar will provide foundational information on how reimbursement works, describe the evolving NGS test reimbursement landscape, and share best practices for increasing coverage.
hosted by Pierian
Panelist: Angela Williams, Field Application Scientist
In this informative webinar Pierian Field Application Scientist, Angela Williams guides you through a clinical genomics report. In this session, she provides a general overview of potential data elements present in a comprehensive genomic profiling somatic report as well as shows configurable options when reporting using PierianDx Clinical Genomics Workspace as a tertiary analysis tool.
hosted by Pierian
Gain valuable insight on selecting the appropriate assay and bioinformatics and reporting methods to ensure that no opportunities to provide the most up-to-date treatment options to patients are missed.
hosted by Pierian
Renee Sears, PhD, Clinical Genomics Specialist, Pierian, and Amber Leigh, Senior Field Application Scientist, Pierian, share key considerations and provide best practices for all phases of assay validation so that you can validate and implement your NGS testing program more efficiently.
hosted by Pierian
Savita Shrivastava, Director of Bioinformatics, PierianDx, discusses key considerations and shares best practices for implementing bioinformatics pipelines in support of in-house NGS testing.
hosted by Pierian
In the second webinar in our educational webinar series on insourcing NGS testing, Dr. Nikoletta Sidiropoulos, University of Vermont, and Dr. Susan Daraiseh, Beaumont Health, share their insourcing success stories.
hosted by Association of Community Cancer Centers
Pierian Founder, Rakesh Nagarajan, MD, PhD, discusses how healthcare organizations can insource NGS testing to improve patient outcomes and differentiate themselves in the process.
hosted by Pierian
Geared toward operational leaders, this webinar covers how leading care providers can realize dramatic clinical, strategic, and financial gains by insourcing their own testing operations.
presenter Joseph Ferrara, President and CEO, Boston Healthcare Associates
Join us for an informative webinar in which Joseph Ferrara, President and CEO of Boston Healthcare Associates, discusses the evolving landscape of NGS test reimbursement.
panelists: Maria Antonietta Cerone and Donald White, CRUK; Somai Man and Deniz Ucanok, Birmingham Women's and Children's NHS Foundation Trust
Researchers from Cancer Research UK (CRUK) and Birmingham Women's and Children's NHS Foundation Trust discuss how a robust variant interpretation and reporting system can help match patients to clinical trials.
hosted by Pierian
Two members of the ASCO guidelines expert volunteer leadership will join as panelists and discuss how guidelines are developed, updated, and disseminated and how they should be used to guide cancer diagnosis and treatment.
Guest Sebastian Dintner, PhD, University of Augsburg
Dr. Sebastian Dintner, Head of Molecular Pathology at the University Hospital of Augsburg, describes how his team is expanding their precision medicine program by enabling genomic testing as a standard of care.
speaker Amber Leigh
In this practice-based webinar, you’ll learn how to analyze complex genomic variants, such as gene fusions, splice-site variants, and co-occurring variants within the context of somatic cancer.
guest C.K. Wang, MD, Chief Medical Officer, Cota Healthcare
In this informative webinar, real-world data expert and Chief Medical Officer at Cota Healthcare, Dr. C.K. Wang, describes the value of real-world data and how healthcare institutions can use these data to improve routine cancer care.
presented by Cates Mallaney and Erin Buck
In this educational webinar, we provide best practices for all phases of validating an RUO-based assay to help your clinical laboratory get your NGS test up and running more quickly.
presented by Mukesh Sharma, PhD, VP Product, and Andy Bredemeyer, PhD, VP Product
In this webinar, we propose sound strategies for sequencing data transfer, analysis, QC, annotation, interpretation, and reporting that are in wide use by the PierianDx clinical community. Best practices will be demonstrated using Clinical Genomics Workspace and our highly-curated, rules-based Clinical Genomics Knowledgebase for the rapid and accurate identification of actionable clinical variants.
guest Amber Leigh, Field Application Scientist
In this practice-based webinar, you’ll learn how to analyze complex genomic variants, such as gene fusions, splice-site variants, and co-occurring variants within the context of somatic cancer.
guest Josepha Ferrara, President, Boston Healthcare
In this informative webinar, PierianDx and Boston Healthcare examine the evolving landscape of NGS test reimbursement and provide strategies for improving the level at which your organization is reimbursed.
guest Rakesh Nagarajan, MD, PhD, Founder, PierianDx
In this informative webinar we will explore how your laboratory can prepare to offer comprehensive genomic profiling assays by discussing strategies for validation, implementation, and reporting.
guest Eric Vail, MD, Director of Molecular Pathology, Cedars-Sinai and Rakesh Nagarajan, MD, PhD, Founder, PierianDx
In this informative webinar, Eric Vail, MD, director of molecular pathology, Cedars-Sinai Medical Center, will discuss how testing programs have positively transformed patient care. Vail will also explain how organizations can maximize the clinical utility of patient reports by leveraging electronic medical record data and standardizing interpretation language.
guest Rakesh Nagarajan, MD, PhD, Founder, PierianDx
In this educational webinar, we explore how your laboratory can rapidly validate, implement, and report using the pan cancer profiling assay.
guest Amber Leigh, Application Scientist
In this practice-based webinar, you’ll learn how to analyze complex genomic alterations, such as gene fusions, splice-site mutations, and co-occurring variants within the context of somatic cancer.
guest: Rakesh Nagarajan, MD, PhD
PierianDx Founder and Executive Chairman, Rakesh Nagarajan, highlights strategic considerations for building an effective clinical NGS testing menu that achieves greater control, cost savings, and better care for patients.
guest Josepha Ferrara, President, Boston Healthcare
In this informative webinar, PierianDx and Boston Healthcare dissect the evolving landscape of NGS test reimbursement. We will provide a toolkit that enables molecular diagnostic laboratories to demonstrate the clinical utility of a test, effectively bill for the test, and communicate value to payors--all to improve reimbursement.
guests: Rakesh Nagarajan, MD, PhD
Clinical NGS has been widely adopted as Laboratory Derived Tests (LDTs). NGS-based in vitro diagnostics (IVD) recently gained FDA approval with many others now in process. These IVD assays facilitate broad, widespread adoption of NGS-based testing globally in cancer and other complex conditions that require timely, accurate diagnoses and treatment. To support comprehensive interpretation of these assays, we have developed the PierianDx KnowledgeBase. Driven by the richest set of curated and rationalized content of medical interpretations, clinical practice guidelines, FDA therapeutics and clinical trials, the PierianDx KnowledgeBase offers the most well-vetted interpretations and classifications of genomic variants for IVD use.
guests: Shalini Verma, MD, FCAP; and Karl Voelkerding, MD, FCAP
Optimism for next generation sequencing (NGS) technologies to be used in a clinical setting quickly turns to numerous conversations about the challenges involved. In this webinar, we discuss the CAP (College of American Pathologists) Distributive Model and how your organization can leverage it to rapidly and economically conduct or scale clinical NGS testing.
guests: Shalini Verma, MD, FCAP; Andy Bredemeyer, PhD
Broader adoption of next-generation sequencing-based cancer testing reveals the challenges associated with variant interpretation and underscores the need to standardize results across molecular pathology labs. Guidelines developed by the Association for Molecular Pathology (AMP) with representation from key institutions, including ACMG, outline a system to categorize sequence variations in cancer.
guests: Eric Loo, MD and Rakesh Nagarjan, MD, PhD
Dartmouth-Hitchcock has experienced nearly 40% savings by bringing NGS testing in-house. A recent AMP study using non-small cell lung cancer as an example cites $2.7 million in anticipated savings. In-house NGS testing is the foundation of any modern precision medicine program. It can have a profound effect on patient care. And, as these examples show, a strong business case can be made.
guests: Ravindra Kolhe, MD, PhD; Karen L. Kaul, MD, PhD; Theresa Ann Boyle, MD, PhD; Mani S. Mahadevan, MD; and Nikoletta Sidiropoulos, MD
How do recent coverage decisions on NGS testing affect you? For academic centers, leading cancer institutions, and essential community cancer centers that have CLIA-certified laboratories providing validated laboratory developed NGS-based tests, the policy would supersede existing local coverage policies for most of those tests and limit Medicare beneficiaries’ access to a single test.
guests: Gregory Tsongalis, MD; Anthony Magliocco, MD; and Ravindra Kolhe, MD
The TST170 next-generation sequencing-based panel targets single nucleotide variants, indels, gene amplifications, gene fusions, splice variants, mRNA expression, and mRNA isoform detection found in 170 cancer-related genes and also calculates metrics such as tumor mutation burden and determines evidence for microsatellite instability. Panelists discuss the design of the assay, data analytics, and reasons behind their selection of the TST170 assay, and will share details of how it is being utilized within their organizations.
guest: Rakesh Nagarajan
PierianDx accelerates precision medicine by offering one space to handle a range of genomic testing, from somatic to constitutional, from small panels to whole exome or genome. During this webinar, PierianDx Chief Biomedical Informatics Officer Dr. Rakesh Nagarajan will provide an overview of CGW and illustrate how the industry leading platform seamlessly manages genomic data and workflow for each case, from variant analysis and classification to interpretation, reporting and final sign out.
guest: Anthony Magliocco, MD
Building a world-class precision medicine program takes the right mix of innovative leadership, advanced technology, clinical acumen, and strategic partnerships. During this webinar, Dr. Anthony Magliocco, the Chair of Anatomic Pathology at Moffitt Cancer Center, will share the Moffitt success story – from its pioneering inception to being one of only 47 Comprehensive Cancer Centers as designated by the National Cancer Institute.
guest: Rakesh Nagarajan
The success of any precision medicine program involves the right combination of personnel and technology. PierianDx’s Clinical Genomicist Workspace (CGW) has been the technology platform of choice for clinical labs to seamlessly manage their genomic data and workflow from variant analysis and classification to interpretation, reporting and final sign out. However, the right strategy and clinical resources at the validation and interpretation stages are just as important to that success. During this webinar, PierianDx Chief Bioinformatics Officer Rakesh Nagarajan will discuss ways clinical labs can improve validation and interpretation approaches to enhance report actionability, relevance and throughput.
guest: Nikoletta Sidiropoulos, MD
Dr. Sidiropoulos shared her experiences and lessons learned as she works to evolve the university’s precision medicine program. Specific examples were shared on how to improve clinical lab workflow, starting with DNA or RNA samples and ending with a report of relevant variants to assist in clinical decision-making. By the end of this webinar, participants will have some real-world examples of how to accelerate their own personalized medicine initiatives from clinical experts in the field.
guests: Allie Grossman, MD; Karl Voelkerding, MD, FCAP; and Rakesh Nagarajan, MD, PhD
This interactive roundtable discusses established and emerging regulatory, scientific, and medical topics related to next-generation sequencing in the clinical setting. An expert panel of leading pathologists, medical geneticists, and researchers will address genomic testing advances in two thematic areas: 1) scientific and clinical trends in reporting, and 2) clinical lab operations and quality management.
Global phone number: (314) 628-0035
U.S. Office: 6 Cityplace Dr Suite 550, Creve Coeur, MO 63141
India Office: 2/A, Chattushringi, Gokhalenagar, Pune, Maharashtra 411016, India